Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice

Detalhes bibliográficos
Autor(a) principal: Ghedini, Paulo César [UNIFESP]
Data de Publicação: 2012
Outros Autores: Avellar, Maria Christina Werneck [UNIFESP], Lima, Thereza Cristina Monteiro de, Lima-Landman, Maria Teresa Riggio de [UNIFESP], Lapa, Antonio José [UNIFESP], Souccar, Caden [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/35500
http://dx.doi.org/10.1016/j.brainres.2012.09.021
Resumo: Lack of dystrophin in Duchenne muscle dystrophy (DMD) and in the mutant mdx mouse results in progressive muscle degeneration, structural changes at the neuromuscular junction, and destabilization of the nicotinic acetylcholine receptors (nAChRs). One-third of DMD patients also present non-progressive cognitive impairments. Considering the role of the cholinergic system in cognitive functions, the number of nAChR binding sites and the mRNA levels of alpha 4, beta 2, and alpha 7 subunits were determined in brain regions normally enriched in dystrophin (cortex, hippocampus and cerebellum) of mdx mice using specific ligands and reverse-transcription polymerase chain reaction assays, respectively. Membrane preparations of these brain regions were obtained from male control and mdx mice at 4 and 12 months of age. the number of [H-3]-cytisine (alpha 4 beta 2) and [I-125]-alpha-bungarotoxin ([I-125]-alpha BGT, alpha 7) binding sites in the cortex and cerebellum was not altered with age or among age-matched control and mdx mice. A significant reduction in [H-3]-cytisine (48%) and [I-125]-alpha BGT (37%) binding sites was detected in the hippocampus of mdx mice at 12 months of age. When compared with the age-matched control groups, the mdx mice did not have significantly altered [H-3]-cytisine binding in the hippocampus, but [I-125]-alpha BGT binding in the same brain region was 52% higher at 4 months and 20% lower at 12 months. mRNA transcripts for the nAChR alpha 4, beta 2, and alpha 7 subunits were not significantly altered in the same brain regions of all animal groups. These results suggest a potential alteration of the nicotinic cholinergic function in the hippocampus of dystrophin-deficient mice, which might contribute to the impairments in cognitive functions, such as learning and memory, that have been reported in the dystrophic murine model and DMD patients. (C) 2012 Elsevier B.V. All rights reserved.
id UFSP_08f344d25606f47e28ea4a11f6a66f84
oai_identifier_str oai:repositorio.unifesp.br:11600/35500
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Ghedini, Paulo César [UNIFESP]Avellar, Maria Christina Werneck [UNIFESP]Lima, Thereza Cristina Monteiro deLima-Landman, Maria Teresa Riggio de [UNIFESP]Lapa, Antonio José [UNIFESP]Souccar, Caden [UNIFESP]Universidade Federal de São Paulo (UNIFESP)Universidade Federal de Santa Catarina (UFSC)Amazon Biotechnol Ctr2016-01-24T14:28:00Z2016-01-24T14:28:00Z2012-11-05Brain Research. Amsterdam: Elsevier B.V., v. 1483, p. 96-104, 2012.0006-8993http://repositorio.unifesp.br/handle/11600/35500http://dx.doi.org/10.1016/j.brainres.2012.09.021WOS000311174900011.pdf10.1016/j.brainres.2012.09.021WOS:000311174900011Lack of dystrophin in Duchenne muscle dystrophy (DMD) and in the mutant mdx mouse results in progressive muscle degeneration, structural changes at the neuromuscular junction, and destabilization of the nicotinic acetylcholine receptors (nAChRs). One-third of DMD patients also present non-progressive cognitive impairments. Considering the role of the cholinergic system in cognitive functions, the number of nAChR binding sites and the mRNA levels of alpha 4, beta 2, and alpha 7 subunits were determined in brain regions normally enriched in dystrophin (cortex, hippocampus and cerebellum) of mdx mice using specific ligands and reverse-transcription polymerase chain reaction assays, respectively. Membrane preparations of these brain regions were obtained from male control and mdx mice at 4 and 12 months of age. the number of [H-3]-cytisine (alpha 4 beta 2) and [I-125]-alpha-bungarotoxin ([I-125]-alpha BGT, alpha 7) binding sites in the cortex and cerebellum was not altered with age or among age-matched control and mdx mice. A significant reduction in [H-3]-cytisine (48%) and [I-125]-alpha BGT (37%) binding sites was detected in the hippocampus of mdx mice at 12 months of age. When compared with the age-matched control groups, the mdx mice did not have significantly altered [H-3]-cytisine binding in the hippocampus, but [I-125]-alpha BGT binding in the same brain region was 52% higher at 4 months and 20% lower at 12 months. mRNA transcripts for the nAChR alpha 4, beta 2, and alpha 7 subunits were not significantly altered in the same brain regions of all animal groups. These results suggest a potential alteration of the nicotinic cholinergic function in the hippocampus of dystrophin-deficient mice, which might contribute to the impairments in cognitive functions, such as learning and memory, that have been reported in the dystrophic murine model and DMD patients. (C) 2012 Elsevier B.V. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Universidade Federal de São Paulo, Escola Paulista Med, Sect Nat Prod, Dept Pharmacol, São Paulo, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Sect Expt Endocrinol, Dept Pharmacol, São Paulo, BrazilUniv Fed Santa Catarina, Dept Pharmacol, Neuropharmacol Lab, Florianopolis, SC, BrazilAmazon Biotechnol Ctr, Lab Pharmacol & Toxicol, Manaus, AM, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Sect Nat Prod, Dept Pharmacol, São Paulo, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Sect Expt Endocrinol, Dept Pharmacol, São Paulo, BrazilWeb of Science96-104engElsevier B.V.Brain Researchhttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyinfo:eu-repo/semantics/openAccessNicotinic acetylcholine receptorDystrophinHippocampusMemorymdx mouseDuchenne muscle dystrophyQuantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient miceinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlereponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000311174900011.pdfapplication/pdf652495${dspace.ui.url}/bitstream/11600/35500/1/WOS000311174900011.pdfd64c0b4830f4668bbb7f88c18859be7fMD51open accessTEXTWOS000311174900011.pdf.txtWOS000311174900011.pdf.txtExtracted texttext/plain43344${dspace.ui.url}/bitstream/11600/35500/2/WOS000311174900011.pdf.txt7615bd5b63287e6298dbc33631038cd5MD52open access11600/355002023-01-12 21:52:30.411open accessoai:repositorio.unifesp.br:11600/35500Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-01-13T00:52:30Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
title Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
spellingShingle Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
Ghedini, Paulo César [UNIFESP]
Nicotinic acetylcholine receptor
Dystrophin
Hippocampus
Memory
mdx mouse
Duchenne muscle dystrophy
title_short Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
title_full Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
title_fullStr Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
title_full_unstemmed Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
title_sort Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice
author Ghedini, Paulo César [UNIFESP]
author_facet Ghedini, Paulo César [UNIFESP]
Avellar, Maria Christina Werneck [UNIFESP]
Lima, Thereza Cristina Monteiro de
Lima-Landman, Maria Teresa Riggio de [UNIFESP]
Lapa, Antonio José [UNIFESP]
Souccar, Caden [UNIFESP]
author_role author
author2 Avellar, Maria Christina Werneck [UNIFESP]
Lima, Thereza Cristina Monteiro de
Lima-Landman, Maria Teresa Riggio de [UNIFESP]
Lapa, Antonio José [UNIFESP]
Souccar, Caden [UNIFESP]
author2_role author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Universidade Federal de Santa Catarina (UFSC)
Amazon Biotechnol Ctr
dc.contributor.author.fl_str_mv Ghedini, Paulo César [UNIFESP]
Avellar, Maria Christina Werneck [UNIFESP]
Lima, Thereza Cristina Monteiro de
Lima-Landman, Maria Teresa Riggio de [UNIFESP]
Lapa, Antonio José [UNIFESP]
Souccar, Caden [UNIFESP]
dc.subject.eng.fl_str_mv Nicotinic acetylcholine receptor
Dystrophin
Hippocampus
Memory
mdx mouse
Duchenne muscle dystrophy
topic Nicotinic acetylcholine receptor
Dystrophin
Hippocampus
Memory
mdx mouse
Duchenne muscle dystrophy
description Lack of dystrophin in Duchenne muscle dystrophy (DMD) and in the mutant mdx mouse results in progressive muscle degeneration, structural changes at the neuromuscular junction, and destabilization of the nicotinic acetylcholine receptors (nAChRs). One-third of DMD patients also present non-progressive cognitive impairments. Considering the role of the cholinergic system in cognitive functions, the number of nAChR binding sites and the mRNA levels of alpha 4, beta 2, and alpha 7 subunits were determined in brain regions normally enriched in dystrophin (cortex, hippocampus and cerebellum) of mdx mice using specific ligands and reverse-transcription polymerase chain reaction assays, respectively. Membrane preparations of these brain regions were obtained from male control and mdx mice at 4 and 12 months of age. the number of [H-3]-cytisine (alpha 4 beta 2) and [I-125]-alpha-bungarotoxin ([I-125]-alpha BGT, alpha 7) binding sites in the cortex and cerebellum was not altered with age or among age-matched control and mdx mice. A significant reduction in [H-3]-cytisine (48%) and [I-125]-alpha BGT (37%) binding sites was detected in the hippocampus of mdx mice at 12 months of age. When compared with the age-matched control groups, the mdx mice did not have significantly altered [H-3]-cytisine binding in the hippocampus, but [I-125]-alpha BGT binding in the same brain region was 52% higher at 4 months and 20% lower at 12 months. mRNA transcripts for the nAChR alpha 4, beta 2, and alpha 7 subunits were not significantly altered in the same brain regions of all animal groups. These results suggest a potential alteration of the nicotinic cholinergic function in the hippocampus of dystrophin-deficient mice, which might contribute to the impairments in cognitive functions, such as learning and memory, that have been reported in the dystrophic murine model and DMD patients. (C) 2012 Elsevier B.V. All rights reserved.
publishDate 2012
dc.date.issued.fl_str_mv 2012-11-05
dc.date.accessioned.fl_str_mv 2016-01-24T14:28:00Z
dc.date.available.fl_str_mv 2016-01-24T14:28:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Brain Research. Amsterdam: Elsevier B.V., v. 1483, p. 96-104, 2012.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/35500
http://dx.doi.org/10.1016/j.brainres.2012.09.021
dc.identifier.issn.none.fl_str_mv 0006-8993
dc.identifier.file.none.fl_str_mv WOS000311174900011.pdf
dc.identifier.doi.none.fl_str_mv 10.1016/j.brainres.2012.09.021
dc.identifier.wos.none.fl_str_mv WOS:000311174900011
identifier_str_mv Brain Research. Amsterdam: Elsevier B.V., v. 1483, p. 96-104, 2012.
0006-8993
WOS000311174900011.pdf
10.1016/j.brainres.2012.09.021
WOS:000311174900011
url http://repositorio.unifesp.br/handle/11600/35500
http://dx.doi.org/10.1016/j.brainres.2012.09.021
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Brain Research
dc.rights.driver.fl_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 96-104
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/35500/1/WOS000311174900011.pdf
${dspace.ui.url}/bitstream/11600/35500/2/WOS000311174900011.pdf.txt
bitstream.checksum.fl_str_mv d64c0b4830f4668bbb7f88c18859be7f
7615bd5b63287e6298dbc33631038cd5
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764120655659008